Navigation Links
Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2009
Date:4/29/2009

on (251,624) (234,393) Property, plant and equipment, net 252,273 218,183 Goodwill 203,871 209,146 Other assets 157,693 150,694 Long term assets of discontinued operations (1) - 3,088 Total assets $2,063,991 $1,975,512 Liabilities and Stockholders' Equity Current liabilities Accounts payable $111,070 $105,281 Accrued expenses 226,756 252,915 Deferred revenues 131,464 141,368 Advance payments from customers 224,082 201,783 Product warranty 48,892 51,141 Short-term borrowings 10,000 - Current maturities of long-term debt 2,746 7,987 Current liabilities of discontinued operations (1) - 21,202 Total current liabilities 755,010 781,677 Other long-term liabilities 152,154 134,251 Long-term debt 29,774 32,399 Total liabilities 936,938 948,327 Stockholders' Equity Common stock 125,360 125,590 Capital in excess of par value 486,584 468,384 Retained earnings and accumulated other comprehensive loss 515,109 433,211 Total stockholders' equity 1,127,053 1,027,185 Total liabilities and stockholders' equity $2,063,991 $1,975,512


'/>"/>

SOURCE Varian Medical Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Varian, Inc. Reports Second Quarter 2009 Results
2. Worlds largest DNA scan for autism uncovers new gene variant for disorder
3. MCG participating in national study to identify genetic variants in schizophrenia
4. Varian Medical Systems to Exhibit Full Spectrum of Prostate Cancer Treatment Technologies at the American Urological Association Meeting in Chicago
5. Image-guided treatment helping women with tubo-ovarian abscesses avoid unnecessary surgery
6. Genetic variants predict recurrence of bladder cancer, patient survival
7. Mayo Clinic-led researchers confirm gene variants associated with the most common adult leukemia
8. Chemo Combo Shows Promise Against Ovarian Cancer
9. Addition of dasatinib to standard chemo cocktail may enhance effect in certain ovarian cancers
10. Varian Medical Systems to Exhibit the Latest X-Ray Image Detectors, and X-Ray Tubes at the CMEF Show in Shenzhen, China
11. Gene Variant Tied to Schizophrenia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2009)...,, RSVfoundtocausefarmoreemergencydepartmentv...STON,Nov.23/PRNewswire-USNewswire/--Influenza,part...ofpublichealthofficials,themediaandthepublic.Howev...atientsseeninitsemergencydepartment(ED)duringsever...rysyncytialvirus(RSV)-takesasubstantiallygreaterdi...
(Date:11/22/2009)..., DALLAS Nov. 23, 2009 UT Southwestern Medical C...ional Institutes of Health to share $56 million ov...sortium (ICAC). , The ICAC, which receives fund...y and Infectious Diseases, investigates novel trea...Dr. Rebecca Gruchalla, chief of allergy and immuno...
(Date:11/22/2009)... WASHINGTON, D.C. November 18, 2009 -- When peopl...parasites, which enter the body from the saliva of...pread to red blood cells. Inside the blood cells, ...dhesive proteins on the cell surface that change t.... , Experiments show that infected red blood cel...
(Date:11/22/2009)...riation can cause donated cells to attack recipien...v. 22 (HealthDay News) -- Researchers are reportin...osts the risk that someone who,s had a bone-marrow...ft-versus-host disease. , The immune system-re...ecipient has the variation and the donor does not....
(Date:11/22/2009)... The holiday season is fill...can be both fun and joyous. It can also be stressf...mbination of stress, fatigue, and high fat foods -...of cancer. That,s why the National Foundation for ...d Tips that can help ensure a happier, more health...
Breaking Medicine News(10 mins):Health News:Amid the Flu Epidemic, Don't Forget RSV in Young Children 2Health News:Amid the Flu Epidemic, Don't Forget RSV in Young Children 3Health News:UT Southwestern receives continued NIH funding for Inner City Asthma Consortium 2Health News:Measuring and modeling blood flow in malaria 2Health News:Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research 2Health News:Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research 3
... drug candidate discovered by Tel Aviv University ...tive treatment against the debilitative Alzheimer,... of diseases where patients suffer from cognitive ...rican patients with mild cognitive damage against ...
...UT HILL, MA A critical enzyme used to prepare a p...rug makers better target the cells the natural pro...he May 23 edition of the Journal of Biological Che...n discovered that one of the enzymes contained in ...
...E, Ariz., May 29 MedTrust Online, LLC, a,provider..., is working with,Oracle, the world,s largest ente... in Information Technology (IT) solutions, to brin...er,patients in the Southwest U.S., By deploying t...
...ELPHIA Researchers from the University of Pennsyl...t of a protein deficiency, which is the basis of t...SMA), is not restricted to motor nerve cells, sugg...PhD, the Isaac Norris Professor of Biochemistry an...
... May 29 HMS Holdings Corp. (Nasdaq:,HMSY) today a... Spring,Investment Conference, which will be held ...ter Hosp, Chief Financial Officer of HMS Holdings ...ion of benefits, and program integrity services fo...
...-year agreement extends alliance members, access t...-invasive temperature therapy ...t Medical Systems, Inc.,today announced its award ...kets, localized heat therapy and cold,therapy syst...
Other Medicine News:Health News:Appealing the death sentence for brain cells 2Health News:Enzyme may hold key to improved targeting of cancer-fighting drugs 2Health News:MedTrust Online Collaborates With Oracle and Dell to Provide Oncologists With the Next Generation Tool for Personalized Care Delivery 2Health News:MedTrust Online Collaborates With Oracle and Dell to Provide Oncologists With the Next Generation Tool for Personalized Care Delivery 3Health News:Penn researchers gain new insights on spinal muscular atrophy 2Health News:Adroit Medical Systems Awarded Premier Supplier Contract for Temperature Therapy Systems 2
(Date:11/20/2009)... , MINNEAPOLIS, Nov. 20 /PRNewswire-FirstCall/...ed results for its first quarter ended September 3...r diluted share, on revenues of $3,263,000. This ... diluted share, on revenues of $3,168,000 for the ...e first quarter results, Biotel President and CEO ...
(Date:11/20/2009)... , MEMPHIS, Tenn., Nov. 20 /PRNewswire-First...aedics Division is pleased to announce the signing...ted States Department of Defense that may lead to ...d to revolutionize the treatment of the limbs of s...st year, the Defense Advanced Research Projects Ag...
(Date:11/19/2009)... , LYON, France, Nov. 19 In r...upplying dangerous and illegal medicines, Operatio...ed by INTERPOL and the World Health Organization,s...g Taskforce (IMPACT) to highlight the dangers of b... initiative resulted in a series of arrests and th...
Breaking Medicine Technology:Biotel Announced Profitable First Quarter Ended September 30, 2009 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2Family Friends Influence Breast Cancer Decisions 56172 1Family Friends Influence Breast Cancer Decisions 56172 2PRC Launches New Web Resource for Teaching Language to Children 26 Adults with Speech Disabilities 56169 1PRC Launches New Web Resource for Teaching Language to Children 26 Adults with Speech Disabilities 56169 2AARP Delivers Strong Health Care Reform Message in a Bottle to Members of Congress 56166 1
...uperGen Inc.,(Nasdaq: SUPG ), a pharmaceutical co...t and commercialization of therapies for solid tum...d at the 13th Congress of the,European Hematology ...-1252, its JAK2 kinase inhibitor, prevents tumor c... oral presentation titled "SGI-1252: A Potent Smal...
...RX Pharmaceuticals,Inc. (Amex: ANX ) today provid...its Phase 2b clinical trial of CoFactor for the tr.... Overall survival results in this,study have been...(5-fluorouracil) arm demonstrating a 14 day improv...in/5-FU arm., "In the Phase 2b study, CoFactor wa...
Other Medicine Technology:SuperGen's JAK2 Inhibitor, SGI-1252, Inhibits in Vivo Tumor Cell Proliferation 2ADVENTRX Announces CoFactor(R) Phase 2b Clinical Trial Overall Survival Results 2ADVENTRX Announces CoFactor(R) Phase 2b Clinical Trial Overall Survival Results 3
Sononav Intraoperative Imaging System
Hemaseel APR
...us device the two steps are performed in sequence ...s' single use disposable cartridge and placed in t...utton, and the cycle begins. The platelet plasma i...yringe pump concentrates fibrinogen, platelets and...
...ow cost, low volume alternative. Whole blood is dr...rom whole blood by centrifugation in a standard cl...e Cebus single use cartridge. The cartridge is the...the concentrating process. Finally, the cartridge ...
Medicine Products: